Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 837.05 INR -0.94%
Market Cap: 149.9B INR

Wall Street
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 938.4 INR with a low forecast of 719.12 INR and a high forecast of 1 260 INR.

Lowest
Price Target
719.12 INR
14% Downside
Average
Price Target
938.4 INR
12% Upside
Highest
Price Target
1 260 INR
51% Upside
Natco Pharma Ltd Competitors:
Price Targets
OFN
Orell Fuessli AG
9% Upside

Revenue
Forecast

18% / Year
Past Growth
-9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
18% / Year
Past Growth
-9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -9%.

Operating Income
Forecast

27% / Year
Past Growth
-33% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
27% / Year
Past Growth
-33% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 13 years the compound annual growth rate for Natco Pharma Ltd's operating income is 27%. The projected CAGR for the next 3 years is -33%.

Net Income
Forecast

30% / Year
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
30% / Year
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Natco Pharma Ltd's net income is 30%. The projected CAGR for the next 3 years is -24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NATCOPHARM's stock price target?
Price Target
938.4 INR

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 938.4 INR with a low forecast of 719.12 INR and a high forecast of 1 260 INR.

What is Natco Pharma Ltd's Revenue forecast?
Projected CAGR
-9%

For the last 13 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -9%.

What is Natco Pharma Ltd's Operating Income forecast?
Projected CAGR
-33%

For the last 13 years the compound annual growth rate for Natco Pharma Ltd's operating income is 27%. The projected CAGR for the next 3 years is -33%.

What is Natco Pharma Ltd's Net Income forecast?
Projected CAGR
-24%

For the last 13 years the compound annual growth rate for Natco Pharma Ltd's net income is 30%. The projected CAGR for the next 3 years is -24%.

Back to Top